Source: European heart journal. Conference titles: ESC Congress. Unidade: FM
Subjects: BETA-BLOQUEADORES (ADMINISTRAÇÃO E DOSAGEM), QUALIDADE DE VIDA, INSUFICIÊNCIA CARDÍACA, QUESTIONÁRIOS, ESTRATÉGIAS TERAPÊUTICAS, CONGRESSO INTERNACIONAL, RESUMOS (EVENTOS)
ABNT
MELO, D. S. B et al. Evaluating the trial strategy fordosage application of beta-blockers and their impact on the quality of life using the Minnesota Living with Heart Failure Questionnairen (MLHFQ). European heart journal. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1093/eurheartj/ehr324. Acesso em: 12 out. 2024. , 2011APA
Melo, D. S. B., Barretto, A. C. P., Oliveira, A. L., Uchida, A. H., Ochiai, M. E., Cardoso, J. N., et al. (2011). Evaluating the trial strategy fordosage application of beta-blockers and their impact on the quality of life using the Minnesota Living with Heart Failure Questionnairen (MLHFQ). European heart journal. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1093/eurheartj/ehr324NLM
Melo DSB, Barretto ACP, Oliveira AL, Uchida AH, Ochiai ME, Cardoso JN, Morgado PC, Ramires JAF. Evaluating the trial strategy fordosage application of beta-blockers and their impact on the quality of life using the Minnesota Living with Heart Failure Questionnairen (MLHFQ) [Internet]. European heart journal. 2011 ; 32 787.[citado 2024 out. 12 ] Available from: https://doi.org/10.1093/eurheartj/ehr324Vancouver
Melo DSB, Barretto ACP, Oliveira AL, Uchida AH, Ochiai ME, Cardoso JN, Morgado PC, Ramires JAF. Evaluating the trial strategy fordosage application of beta-blockers and their impact on the quality of life using the Minnesota Living with Heart Failure Questionnairen (MLHFQ) [Internet]. European heart journal. 2011 ; 32 787.[citado 2024 out. 12 ] Available from: https://doi.org/10.1093/eurheartj/ehr324